coronavirus
Healthcare
Bharat Biotech says Covid vaccine shows 81% interim efficacy
Bharat Biotech's homegrown Covid-19 vaccine has shown an interim vaccine efficacy of 81% in late-stage clinical trials, the Indian company ......
Markets
Indian shares end higher as Reliance surges on airwaves purchase
Indian shares ended sharply higher on Wednesday as heavyweight Reliance Industries jumped on winning $8 billion worth of airwaves in ......
Healthcare
UK to get 10 mn AstraZeneca Covid vaccine doses from Serum Institute
The UK will receive 10 million AstraZeneca Covid-19 vaccine doses made by the Serum Institute of India (SII), the UK ......
Healthcare
J&J working to bring very high capacity plant in India: Exec
Johnson & Johnson is waiting on regulatory approval of a new, larger plant operated by contract manufacturer Catalent Inc to ......
Healthcare
Brazil prosecutors seek to stop purchase of Indian vaccine
Brazilian prosecutors are seeking the immediate suspension of purchases of India's COVID-19 vaccine COVAXIN, according to a document seen by ......
TMT
Orios managing partner on the virus preparing a windfall for tech startups
Orios Venture Partners has launched two seed funds having investments in companies such as online pharmacy startup PharmEasy, dairy startup ......
Markets
Indian shares drop as investors take profits, virus worries weigh
Broad-based losses pulled Indian shares lower on Monday as investors locked in profits in high-flying stocks, while news of fresh ......
Healthcare
Serum Institute says prioritising India vaccine needs, asks other nations for patience
Serum Institute of India (SII), the world's biggest vaccine maker by volume, on Sunday asked for patience from foreign governments ......
Healthcare
Krsnaa Diagnostics ropes in investment bankers for flotation
Pune-based chain Krsnaa Diagnostics has lined up book-running lead managers to take the company public in the first half of ......
Healthcare
India's Biological E looking to make 600 mn J&J vaccine shots a year
Indian pharmaceutical company Biological E Ltd is looking to contract-manufacture roughly 600 million doses of Johnson and Johnson's COVID-19 vaccine ......
